Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011 Sep 16; 146(6):904-17.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Azepines
Benzodiazepines
Cell Line, Tumor
Disease Models, Animal
Drug Discovery
Humans
Mice
Multiple Myeloma
Nuclear Proteins
Protein Structure, Tertiary
Proto-Oncogene Proteins c-myc
Transcriptional Activation
Triazoles
authors with profiles
Constantine S Mitsiades, Ph.D., M.D.
Kenneth Carl Anderson, M.D.
Jun Qi, Ph.D.
Irene Ghobrial, M.D.
William Chun Hahn, Ph.D., M.D.
Paul Gerard Guy Richardson, M.B.,B.S.